About 300 reports

  • Small molecule antiviral therapeutic targeting XPO1 to prevent RSV virion assembly
  • 8.1.1 DEVELOPMENT OF RSV ANTIVIRAL THERAPEUTICS WITH DIVERSE MECHANISMS OF ACTION

With antivirals, one of the problems is to demonstrate efficacy in populations really at risk.

  • Vaccine
  • United States
  • Forecast
  • Novavax, Inc.
  • RSV LRTI group

The Global Influenza Market Chapter ## Introduction Influenza Overview Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials Related BCC Research Reports Chapter ## Summary and Highlights The Influenz

  • Influenza
  • Therapy
  • Vaccine
  • World
  • 3.3 UPCOMING RELATED REPORTS

TABLE ##: PEDIATRIC VACCINATION RATE TRENDS IN EUROPE (%) ##. ##% ##. ##% ##. ##% Source: GlobalData; COVER, 2010-2018; MSS, 2010; MSS, 2012a-d; MSS, 2013a-b; MSS, 2014a-c; MSS, 2015a-b; MSS, 2016a-b; MSS, 2017ab; MSSSI, 2017; Rieck et al., 2014; Signorelli et al., 2018 *DT-IPV, ≥## doses, ## yea

  • Vaccine
  • Japan
  • North America
  • Merck & Co., Inc.
  • Sanofi S.A.

PASSPORT ## Rx antivirals OTC products for the flu do not treat the flu itself, they merely treat its symptoms, and, though some patients are prescribed antibiotics for infections associated with the flu, the only products that can actually treat the disease itself are antivirals,

  • Influenza
  • Vaccine
  • United States
  • Demand
  • Mondelez International, Inc.

Top ## players hold majority of stake in the market ##.

  • Cardiovascular Disease
  • Diabetes
  • Endocrine Disease
  • Pathology
  • Vaccine
  • GLAXOSMITHKLINE

The company operates in different pharmaceutical sectors such as respiratory, antivirals, neurological, cardiovascular, urogenital, and oncology.

  • Infectious Disease
  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • COMMERCIAL ASSESSMENT - LEADING MARKETED PRODUCTS

THE SEASONAL INFLUENZA ANTIVIRALS MARKET IS DOMINATED BY ROCHE IN THE US AND EUROPE, AND BY DAIICHI SANKYO IN JAPAN.

  • Vaccine
  • United States
  • Roche Group
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • 6. COMPETITIVE LANDSCAPE

TABLE OF CONTENTS ##.

  • Vaccine
  • AstraZeneca PLC
  • CSL Limited
  • GlaxoSmithKline plc
  • Indian Immunologicals Ltd

You can easily book an appointment with one online.

  • Vaccine
  • Baxter International Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • Terumo Corporation

##.

  • Therapy
  • Vaccine
  • World
  • Market Size

Traditionally, a blockbuster drug is defined as one with annual sales of more than USD ## billion.

  • Vaccine
  • North America
  • United States
  • Market Size
  • F. Hoffmann-La Roche Ltd.

The auto exports exceeded over ## million each year.

  • Diagnostics
  • Interferon
  • Vaccine
  • China
  • Demand

The auto exports exceeded over ## million each year.

  • Vaccine
  • China
  • Demand
  • Market Size
  • Trade

(c) AZOTH Analytics ##.

  • Vaccine
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.

Among these major producers, ## located in Jiangsu, ## in Zhejiang, ## in Beijing, ## in Guangdong, ## in Liaoning, ## in Shandong, ## in Shanghai, ## in Henan, ## in Hunan, ## in Hebei, ## in Hubei, ## in Jilin, ## in Jiangxi, ## in Tianjin, ## in Yunan, ## in Chongqing, ## in Heilongjiang,

  • Vaccine
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.

Ltd. and Shanghai No. ## Pharmaceutical Co.

  • Vaccine
  • China
  • Demand
  • Market Size
  • Dongguan Winnerway Bio-Tech Co., Ltd.

TABLE ##. ## SUMMARIZES THE AVAILABILITY OF ANTIVIRALS IN PREFILLED SYRINGES.

  • Vaccine
  • North America
  • United States
  • World
  • West Pharmaceutical Services, Inc.
  • Seasonal Influenza Therapeutics Market, Treatment Algorithm of Seasonal Influenza
  • 2.7 TREATMENT OPTIONS

Antiviral Research; ##(##): ##-## Black S, et al. (2010).

  • Therapy
  • Vaccine
  • Market Size
  • Daiichi Sankyo Company
  • Sanofi S.A.

PLOS ONE; ##(##): E##.

  • Vaccine
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Competitive Assessment o

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

2025 ## Table ##: Key Launch Dates ## Table ##: High-Prescribing Physicians (non-KOLs) Surveyed, By Country ## ##. ## List of Figures Figure ##: Influenza Virus Structure ## Figure ##: Seasonal Influenza Vaccines - Phase II/ Phase III Pipeline, 2016 ## Figure ##: Competitive Assessment o

  • Influenza
  • Therapy
  • Vaccine
  • World
  • Demand

You can easily book an appointment with one online.

  • Vaccine
  • World
  • Antares Pharma, Inc.
  • Endo International plc
  • Inovio Pharmaceuticals, Inc.

Also embedded in the lipid membrane is the M## protein, which is the target of the antiviral adamantanes - amantadine and rimantadine.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size

Measles is one of the major causes of death among young children.

  • Vaccine
  • World
  • Market Size
  • Merck & Co., Inc.
  • Sanofi S.A.
  • PARTNERSHIP BETWEEN ASTELLAS PHARMA AND CLEARPATH DEVELOPMENT COMPANY
  • GROWING STRATEGIC COLLABORATIONS FOSTERING INNOVATION

RIBAVIRIN IS USED AS AN ANTIVIRAL THERAPY FOR THE TREATMENT OF SEVERE RSV DISEASE IN HIGH-RISK INDIVIDUALS.

  • Vaccine
  • World
  • AbbVie Inc.
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • INTRANASAL VACCINES

H##N## vaccines delivered INTRANASAL VACCINES intranasally work by triggering antiviral antibodies in the nose.

  • Vaccine
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Sanofi S.A.
  • Pipeline Valuation
  • GLOBAL SALES ($M) FOR RSV THERAPEUTICS AND PROPHYLACTICS BY PRODUCT CLASS, 2014-2024

Broad-spectrum antiviral activity of Virazole: ##-beta-D-ribofuranosyl- ##, ##, ##-triazole-##-carboxamide.

  • Vaccine
  • Ablynx NV
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • MedImmune, LLC
  • BUSINESS SEGMENTATION BY REVENUE
  • MERCK

It has also signed a contract worth $## billion with Modern Pharmaceuticals for its messenger RNA therapeutics platform for developing new antiviral vaccines and passive immunity therapies.

  • Vaccine
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.

Also embedded in the lipid membrane is the M## protein, which is the target of the antiviral adamantanes - amantadine and rimantadine.

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size

One egg is about enough for one dose.

  • Influenza
  • Vaccine
  • Western Europe
  • Forecast
  • Market Size